196 related articles for article (PubMed ID: 24614661)
1. Toll-like receptor 2-dependent protection against pneumococcal carriage by immunization with lipidated pneumococcal proteins.
Moffitt K; Skoberne M; Howard A; Gavrilescu LC; Gierahn T; Munzer S; Dixit B; Giannasca P; Flechtner JB; Malley R
Infect Immun; 2014 May; 82(5):2079-86. PubMed ID: 24614661
[TBL] [Abstract][Full Text] [Related]
2. T(H)17-Mediated Protection against Pneumococcal Carriage by a Whole-Cell Vaccine Is Dependent on Toll-Like Receptor 2 and Surface Lipoproteins.
Moffitt K; Howard A; Martin S; Cheung E; Herd M; Basset A; Malley R
Clin Vaccine Immunol; 2015 Aug; 22(8):909-16. PubMed ID: 26041040
[TBL] [Abstract][Full Text] [Related]
3. Protection against Pneumococcal colonization and fatal pneumonia by a trivalent conjugate of a fusion protein with the cell wall polysaccharide.
Lu YJ; Forte S; Thompson CM; Anderson PW; Malley R
Infect Immun; 2009 May; 77(5):2076-83. PubMed ID: 19255193
[TBL] [Abstract][Full Text] [Related]
4. T(H)17-based vaccine design for prevention of Streptococcus pneumoniae colonization.
Moffitt KL; Gierahn TM; Lu YJ; Gouveia P; Alderson M; Flechtner JB; Higgins DE; Malley R
Cell Host Microbe; 2011 Feb; 9(2):158-65. PubMed ID: 21320698
[TBL] [Abstract][Full Text] [Related]
5. A Combination of Recombinant Mycobacterium bovis BCG Strains Expressing Pneumococcal Proteins Induces Cellular and Humoral Immune Responses and Protects against Pneumococcal Colonization and Sepsis.
Goulart C; Rodriguez D; Kanno AI; Converso TR; Lu YJ; Malley R; Leite LCC
Clin Vaccine Immunol; 2017 Oct; 24(10):. PubMed ID: 28768668
[TBL] [Abstract][Full Text] [Related]
6. Identification of SP1683 as a pneumococcal protein that is protective against nasopharyngeal colonization.
Moens L; Hermand P; Wellens T; Wuyts G; Derua R; Waelkens E; Ysebaert C; Godfroid F; Bossuyt X
Hum Vaccin Immunother; 2018 May; 14(5):1234-1242. PubMed ID: 29400602
[TBL] [Abstract][Full Text] [Related]
7. Intranasal Immunization with the Commensal
Shekhar S; Khan R; Schenck K; Petersen FC
Appl Environ Microbiol; 2019 Mar; 85(6):. PubMed ID: 30683742
[No Abstract] [Full Text] [Related]
8. Expression of Toll-Like Receptor 2 by Dendritic Cells Is Essential for the DnaJ-ΔA146Ply-Mediated Th1 Immune Response against Streptococcus pneumoniae.
Wang X; Yuan T; Yuan J; Su Y; Sun X; Wu J; Zhang H; Min X; Zhang X; Yin Y
Infect Immun; 2018 Mar; 86(3):. PubMed ID: 29229733
[TBL] [Abstract][Full Text] [Related]
9. Immunization with pneumococcal elongation factor Tu enhances serotype-independent protection against Streptococcus pneumoniae infection.
Nagai K; Domon H; Maekawa T; Hiyoshi T; Tamura H; Yonezawa D; Habuka R; Saitoh A; Terao Y
Vaccine; 2019 Jan; 37(1):160-168. PubMed ID: 30442480
[TBL] [Abstract][Full Text] [Related]
10. Protective Immune Responses Elicited by Fusion Protein Containing PsaA and PspA Fragments.
Lu J; Sun T; Wang D; Dong Y; Xu M; Hou H; Kong FT; Liang C; Gu T; Chen P; Sun S; Lv X; Jiang C; Kong W; Wu Y
Immunol Invest; 2015; 44(5):482-96. PubMed ID: 26107747
[TBL] [Abstract][Full Text] [Related]
11. Protection Elicited by Nasal Immunization with Recombinant Pneumococcal Surface Protein A (rPspA) Adjuvanted with Whole-Cell Pertussis Vaccine (wP) against Co-Colonization of Mice with Streptococcus pneumoniae.
Tostes RO; Rodrigues TC; da Silva JB; Schanoski AS; Oliveira ML; Miyaji EN
PLoS One; 2017; 12(1):e0170157. PubMed ID: 28103277
[TBL] [Abstract][Full Text] [Related]
12. Impaired innate and adaptive immunity to Streptococcus pneumoniae and its effect on colonization in an infant mouse model.
Bogaert D; Weinberger D; Thompson C; Lipsitch M; Malley R
Infect Immun; 2009 Apr; 77(4):1613-22. PubMed ID: 19168741
[TBL] [Abstract][Full Text] [Related]
13. [Toll-like receptor 2 and Toll-like receptor 4 participates in mediation of acute otitis media and mortality in pneumococcal infections in mice].
Li SL; Zhang MY; Li BY; Zheng QY; Zhu HL
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Dec; 46(12):1009-18. PubMed ID: 22336013
[TBL] [Abstract][Full Text] [Related]
14. Lipidation of Pneumococcal Antigens Leads to Improved Immunogenicity and Protection.
Voß F; van Beek LF; Schwudke D; Ederveen THA; van Opzeeland FJ; Thalheim D; Werner S; de Jonge MI; Hammerschmidt S
Vaccines (Basel); 2020 Jun; 8(2):. PubMed ID: 32560374
[No Abstract] [Full Text] [Related]
15. Th17-Mediated Cross Protection against Pneumococcal Carriage by Vaccination with a Variable Antigen.
Kuipers K; Jong WSP; van der Gaast-de Jongh CE; Houben D; van Opzeeland F; Simonetti E; van Selm S; de Groot R; Koenders MI; Azarian T; Pupo E; van der Ley P; Langereis JD; Zomer A; Luirink J; de Jonge MI
Infect Immun; 2017 Oct; 85(10):. PubMed ID: 28717032
[TBL] [Abstract][Full Text] [Related]
16. Lipidation of pneumococcal proteins enables activation of human antigen-presenting cells and initiation of an adaptive immune response.
Paulikat AD; Schwudke D; Hammerschmidt S; Voß F
Front Immunol; 2024; 15():1392316. PubMed ID: 38711516
[No Abstract] [Full Text] [Related]
17. Bacterial surface lipoproteins mediate epithelial microinvasion by
Chan JM; Ramos-Sevillano E; Betts M; Wilson HU; Weight CM; Houhou-Ousalah A; Pollara G; Brown JS; Heyderman RS
Infect Immun; 2024 May; 92(5):e0044723. PubMed ID: 38629841
[No Abstract] [Full Text] [Related]
18. Streptococcus pneumoniae fructose-1,6-bisphosphate aldolase, a protein vaccine candidate, elicits Th1/Th2/Th17-type cytokine responses in mice.
Elhaik Goldman S; Dotan S; Talias A; Lilo A; Azriel S; Malka I; Portnoi M; Ohayon A; Kafka D; Ellis R; Elkabets M; Porgador A; Levin D; Azhari R; Swiatlo E; Ling E; Feldman G; Tal M; Dagan R; Mizrachi Nebenzahl Y
Int J Mol Med; 2016 Apr; 37(4):1127-38. PubMed ID: 26935978
[TBL] [Abstract][Full Text] [Related]
19. Antibody-independent, CD4+ T-cell-dependent protection against pneumococcal colonization elicited by intranasal immunization with purified pneumococcal proteins.
Basset A; Thompson CM; Hollingshead SK; Briles DE; Ades EW; Lipsitch M; Malley R
Infect Immun; 2007 Nov; 75(11):5460-4. PubMed ID: 17698570
[TBL] [Abstract][Full Text] [Related]
20. Mucosal immunization with recombinant fusion protein DnaJ-ΔA146Ply enhances cross-protective immunity against Streptococcus pneumoniae infection in mice via interleukin 17A.
Liu Y; Wang H; Zhang S; Zeng L; Xu X; Wu K; Wang W; Yin N; Song Z; Zhang X; Yin Y
Infect Immun; 2014 Apr; 82(4):1666-75. PubMed ID: 24491576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
